Target intelligence / Profile preview

Ribosomal protein L36a-like pseudogene

Molecular classification
Processed pseudogene
01

Overview

The entry "ribosomal protein L36a-like pseudogene" (noted in Ensembl as ENSG00000270378) refers to a processed pseudogene related to the genuine ribosomal protein L36a (RPL36A) and its closely related functional paralog RPL36A-like (RPL36AL)[1][3][5][6]. Pseudogenes are segments of DNA that resemble genes but are generally considered nonfunctional due to mutations or truncations that prevent them from being transcribed or translated into functional proteins. There are many processed pseudogenes for ribosomal proteins scattered throughout the human genome[4][5]. Pseudogenes do not encode active proteins and are not considered therapeutic targets, receptors, enzymes, or regulatory proteins. They rarely have a direct biological function or disease association and have no established role as drug targets, disease biomarkers, or pharmacological mechanisms. Key Details: - "Ribosomal protein L36a-like pseudogene" by definition is not a protein-coding gene and does not produce a functional protein[1][4][5]. - The gene product is not a receptor, enzyme, transporter, or other classically defined molecular target. - While some pseudogenes can have regulatory effects (e.g., acting as miRNA sponges), no such function is clearly reported for this pseudogene in available sources. - At least dozens of "ribosomal protein L36a pseudogenes" exist in the human genome, each distinguished by a numeral (e.g., RPL36AP1, RPL36AP10)[3]. Summary: This entry refers to a genomic pseudogene, not an active protein or drug target[1][3][5]. There is nothing to suggest therapeutic targeting or disease relevance. The name is correct for the pseudogene class, but this is not a therapeutic target and should be distinguished from its protein-coding relatives RPL36A or RPL36AL[1][2][3][4][5].

Other names
RPL36APribosomal protein L36a pseudogeneRPL36A pseudogeneribosomal protein L36a-like pseudogene

Beyond the preview

Go deeper on Ribosomal protein L36a-like pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36a-like pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call